Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Anglesio

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Cell Death & Disease|January 10, 2019
HACE1 is a potential tumor suppressor in osteosarcomaAmal M El-Naggar, Paul W Clarkson, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial CarcinomaAline Talhouk, Heather Derocher, Pascal Schmidt, et al.
Plos One|June 9, 2017
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutationSatoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumorsYemin Wang, Jiamin Chen, Winnie Yang, et al.
International Journal of Oncology|July 4, 2012
Cytokine gene expression signature in ovarian clear cell carcinomaNozomu Yanaihara, Michael S Anglesio, Kazunori Ochiai, et al.
Molecular and Cellular Biology|December 16, 2005
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA speciesValentina Evdokimova, Peter Ruzanov, Michael S Anglesio, et al.
Genes, Chromosomes & Cancer|July 16, 2009
Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysisKylie L Gorringe, Manasa Ramakrishna, Louise H Williams, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelinesStefan Kommoss, Michael S Anglesio, Robertson Mackenzie, et al.
The Journal of Pathology. Clinical Research|October 1, 2021
Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear featuresEun Young Kang, Nicholas Jp Wiebe, Christa Aubrey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian CancerJohn P Stamp, C Blake Gilks, Martine Wesseling, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Cell Death & Disease|January 10, 2019
HACE1 is a potential tumor suppressor in osteosarcomaAmal M El-Naggar, Paul W Clarkson, Gian Luca Negri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
Molecular Subtype Not Immune Response Drives Outcomes in Endometrial CarcinomaAline Talhouk, Heather Derocher, Pascal Schmidt, et al.
Plos One|June 9, 2017
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutationSatoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, et al.
Neoplasia (New York, N.Y.)|September 27, 2015
The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumorsYemin Wang, Jiamin Chen, Winnie Yang, et al.
International Journal of Oncology|July 4, 2012
Cytokine gene expression signature in ovarian clear cell carcinomaNozomu Yanaihara, Michael S Anglesio, Kazunori Ochiai, et al.
Molecular and Cellular Biology|December 16, 2005
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA speciesValentina Evdokimova, Peter Ruzanov, Michael S Anglesio, et al.
Genes, Chromosomes & Cancer|July 16, 2009
Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysisKylie L Gorringe, Manasa Ramakrishna, Louise H Williams, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 26, 2013
FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelinesStefan Kommoss, Michael S Anglesio, Robertson Mackenzie, et al.
The Journal of Pathology. Clinical Research|October 1, 2021
Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear featuresEun Young Kang, Nicholas Jp Wiebe, Christa Aubrey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2016
BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian CancerJohn P Stamp, C Blake Gilks, Martine Wesseling, et al.
Pageof 9